★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

RNAM

Avidity Biosciences Inc · Healthcare · Biotechnology

72.86 +0.1% mkt cap $11.26B quote delayed (FMP) · as of Oct 11 03:53 UTC — separate from filing data below

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
13Tracked holders
-1Δ holders
64.96MShares held
$1.84BReported value
+1New positions
−2Exits
Falling Conviction score 46/100 4 quarters of rising tracked shares ●●●●○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth -7.1% · share flow -2.1% · net new positions -7.7% — formula
Broad distribution — falling shares and fewer holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q4 2025 103 +3 81.99M $5.91B +5 −1
Q3 2025 15 0 78.61M $3.43B — −1
Q2 2025 13 -1 64.96M $1.84B +1 −2
Q1 2025 11 -2 31.61M $933.16M — −2
Q4 2024 13 +1 31.55M $918.65M +1 —
Q3 2024 11 0 25.98M $1.19B +1 −1
Q2 2024 11 — 22.12M $903.80M — —
Holder count
Who holds it · Q2 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 Fidelity (FMR) ✦ 16.19M — $459.68M 0.0% n/c 1 SEC ↗ ×5
2 T. Rowe Price ✦ 10.81M -4.7% $306.97M 0.0% ▼ Trim 5 SEC ↗ ×2
3 BlackRock ✦ (passive) 9.34M — $265.17M 0.0% n/c 1 SEC ↗ ×15
4 Wellington Management ✦ 9.25M -4.5% $262.69M 0.0% ▼ Trim 5 SEC ↗ ×9
5 The Vanguard Group ✦ (passive) 9.25M — $262.65M 0.0% n/c 1 SEC ↗ ×5
6 State Street Global Advisors ✦ (passive) 4.20M -2.8% $119.32M 0.0% ▼ Trim 3 SEC ↗
7 Geode Capital Management ✦ (passive) 2.85M +3.4% $80.89M 0.0% ▲ Add 5 SEC ↗ ×2
8 Adage Capital Partners ✦ 1.53M -28.8% $43.37M 0.1% ▼ Trim 5 SEC ↗
9 Norges Bank ✦ (passive) 995.12K +18.7% $28.26M 0.0% ▲ Add 4 SEC ↗
10 D. E. Shaw & Co. ✦ 237.40K New $6.74M 0.0% New 1 SEC ↗
11 Millennium Management ✦ 236.99K +1290.1% $6.73M 0.0% ▲ Add 5 SEC ↗
12 Marshall Wace ✦ 60.22K -86.8% $1.71M 0.0% ▼ Trim 5 SEC ↗ ×2
13 Citadel Advisors ✦ 21.72K +34.2% $616,905 0.0% ▲ Add 3 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

D. E. Shaw & Co. $6.74M 0.0%

Exited

Two Sigma Investments $826,560 was 0.0%
AQR Capital Management $318,374 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 8.00K shares, $236,160 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q2 2025 · Methodology · Get this via the API